The Endoscopic Linear Stapler segmentation by application delineates four primary surgical domains: colorectal, gastric, thoracic, and bariatric procedures. Colorectal surgeries, driven by rising incidence of colorectal cancer and minimally invasive resections, represent the largest share, accounting for roughly 35 % of total market revenue. Gastric applications, encompassing sleeve gastrectomy and gastric bypass, contribute about 25 % as obesity rates climb globally. Thoracic procedures—lung resections and esophagectomy—hold a 20 % slice, reflecting expanding thoracoscopic interventions. Bariatric uses, though niche, capture 15 % of the market, propelled by demand for less invasive weight‑loss surgeries. The residual 5 % aggregates miscellaneous uses such as urological and gynecological stapling. Each application segment influences overall market size through distinct procedural volumes, reimbursement landscapes, and device‑specific performance criteria, collectively shaping product development and pricing strategies across the Endoscopic Linear Stapler market.